We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+26.52%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$537M
AUM Growth
-$72.8M
(-12%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-21.68%
Top 10 Holdings %
Top 10 Hldgs %
8.85%
Holding
430
New
151
Increased
31
Reduced
82
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$3.92M |
| 2 |
Amphastar Pharmaceuticals
AMPH
|
+$3.54M |
| 3 |
Veeco
VECO
|
+$3.21M |
| 4 |
Monarch Casino & Resort
MCRI
|
+$3.1M |
| 5 |
Nicolet Bankshares
NIC
|
+$3.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aehr Test Systems
AEHR
|
+$5.57M |
| 2 |
Champion Homes
SKY
|
+$5.47M |
| 3 |
Boot Barn
BOOT
|
+$5.08M |
| 4 |
Identive
INVE
|
+$4.9M |
| 5 |
Impinj
PI
|
+$4.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.67% |
| 2 | Healthcare | 17.17% |
| 3 | Energy | 16.86% |
| 4 | Technology | 12.11% |
| 5 | Materials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGIO
1
DELISTED
Edgio, Inc. Common Stock
EGIO
| $5.7M | 1.06% |
27,288
+16,910
| +163% | +$2.82M |
|
2
LSB Industries
LXU
$881M
| $5.1M | 0.95% |
233,407
-142,291
| -38% | -$2.1M |
|
|
CUTR
3
DELISTED
Cutera, Inc.
CUTR
| $4.96M | 0.92% |
+71,854
| New | +$2.91M |
|
|
KZR
4
DELISTED
Kezar Life Sciences
KZR
| $4.88M | 0.91% |
29,356
-4,880
| -14% | -$700K |
|
|
CTIC
5
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $4.73M | 0.88% |
+1,011,935
| New | +$3.02M |
|
|
NXRT
6
NexPoint Residential Trust
NXRT
$665M
| $4.61M | 0.86% |
51,095
-1,228
| -2% | -$102K |
|
|
7
Amphastar Pharmaceuticals
AMPH
$825M
| $4.48M | 0.83% |
+124,697
| New | +$3.54M |
|
8
Metallus
MTUS
$873M
| $4.45M | 0.83% |
203,234
+133,672
| +192% | +$2.35M |
|
|
SRRA
9
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.38M | 0.82% |
+136,692
| New | +$3.92M |
|
10
Lantheus
LNTH
$6.82B
| $4.26M | 0.79% |
+77,031
| New | +$2.89M |
|
11
Vaalco Energy
EGY
$594M
| $4.09M | 0.76% |
626,861
+262,595
| +72% | +$1.37M |
|
|
HDSN
12
Hudson Technologies
HDSN
$267M
| $4.09M | 0.76% |
658,959
+133,745
| +25% | +$593K |
|
|
VTNR
13
DELISTED
Vertex Energy, Inc
VTNR
| $4.06M | 0.76% |
+408,532
| New | +$2.5M |
|
|
NEX
14
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $3.93M | 0.73% |
+425,096
| New | +$3.05M |
|
15
Rambus
RMBS
$10.4B
| $3.8M | 0.71% |
119,154
-18,206
| -13% | -$504K |
|
16
Axcelis
ACLS
$4.12B
| $3.76M | 0.7% |
49,794
-11,176
| -18% | -$763K |
|
|
TWNK
17
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $3.67M | 0.68% |
167,376
+87,643
| +110% | +$1.82M |
|
|
18
Monarch Casino & Resort
MCRI
$2.14B
| $3.62M | 0.67% |
+41,463
| New | +$3.1M |
|
19
Andersons Inc
ANDE
$2.65B
| $3.58M | 0.67% |
+71,241
| New | +$3M |
|
20
MGP Ingredients
MGPI
$378M
| $3.56M | 0.66% |
41,615
-1,173
| -3% | -$94.5K |
|
21
RPC Inc
RES
$1.24B
| $3.49M | 0.65% |
+326,788
| New | +$2.61M |
|
22
Warrior Met Coal
HCC
$4.23B
| $3.45M | 0.64% |
+92,846
| New | +$2.97M |
|
23
Pacira BioSciences
PCRX
$1.02B
| $3.44M | 0.64% |
+45,145
| New | +$3.01M |
|
24
Chord Energy
CHRD
$7.79B
| $3.44M | 0.64% |
23,534
+10,429
| +80% | +$1.44M |
|
25
Patterson-UTI
PTEN
$3.87B
| $3.43M | 0.64% |
+221,307
| New | +$2.79M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q1 2022 Portfolio in Review
As of Q1 2022, EAM Investors held 430 positions worth $537M, down 12% from $610M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
EAM Investors withdrew a net $116M in Q1 2022, closing 160 positions and reducing 82 holdings. Its most notable exit was Aehr Test Systems, an estimated $5.57M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Energy.
Against the trend, EAM Investors opened a new position in Sierra Oncology, Inc. Common Stock worth $4.38M.
- EAM Investors's largest Q1 2022 buy was Sierra Oncology, Inc. Common Stock: 136,692 shares worth $4.38M.
- EAM Investors added most to Edgio, Inc. Common Stock in Q1 2022, an estimated $2.82M increase.
- EAM Investors's biggest Q1 2022 reduction was Clearfield, cutting an estimated $2.4M.
- EAM Investors fully exited Aehr Test Systems in Q1 2022, selling an estimated $5.57M.
- EAM Investors's ten largest holdings make up 8.9% of its $537M portfolio in Q1 2022.
- EAM Investors opened 151 new positions and closed 160 in Q1 2022.
- EAM Investors's portfolio value fell 12% quarter-over-quarter to $537M.
Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.